Emergence of gentamicin-resistant Klebsiella in a general hospital

Insights

Gentamicin resistance in Klebsiella emerged after 7 years of use. R-factor mediated resistance, often co-transferring other antibiotic resistances, was observed in multiple strains, though all remained susceptible to amikacin and netilmicin.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Gentamicin has been widely used in hospitals for over seven years.
  • The emergence of gentamicin-resistant Klebsiella strains was observed after a significant period of gentamicin use.
  • Klebsiella infections pose a significant challenge in healthcare settings, particularly in patients with indwelling devices.

Purpose of the Study:

  • To investigate the emergence and characteristics of gentamicin-resistant Klebsiella strains in a general hospital.
  • To identify the mechanisms of resistance and the epidemiological spread of these resistant strains.
  • To assess the susceptibility patterns of resistant Klebsiella to other available antibiotics.

Main Methods:

  • Isolation and characterization of Klebsiella strains from patients between 1974 and 1975.
  • Determination of antibiotic resistance profiles, including R-factor mediated resistance.
  • Epidemiological investigation of strain transmission, particularly in patients with urinary catheters.
  • Antimicrobial susceptibility testing against various antibiotics, including amikacin and netilmicin.

Main Results:

  • Nine distinct gentamicin-resistant Klebsiella serobiotypes were isolated from 35 patients.
  • The initial resistant strain exhibited R-factor mediated gentamicin resistance and spread via patient-to-patient transmission, primarily in catheterized patients.
  • This strain appeared to lose its resistance transfer capability after infecting five patients.
  • Other resistant strains had limited persistence and patient involvement.
  • Four of these strains, along with the initial strain, co-transferred resistance to kanamycin, neomycin, and tobramycin.
  • All isolated gentamicin-resistant Klebsiella strains remained susceptible to amikacin and netilmicin.

Conclusions:

  • The emergence of gentamicin resistance in Klebsiella is linked to R-factor mediated mechanisms.
  • Hospital-acquired infections with resistant Klebsiella can spread through patient-to-patient contact, especially in vulnerable populations.
  • The emergence of resistance did not significantly impact the effectiveness of newer antibiotics like amikacin and netilmicin against these strains.
  • Understanding resistance mechanisms and transmission dynamics is crucial for infection control strategies.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...